News FDA Panel Nixes Melblez Kit for Ocular Melanoma Metastases by Medscape • 2013/05/03 • 0 Comments High toxicity and risk for early death outweigh potential survival benefits, say Oncologic Drug Advisory Committee members. Medscape Medical News Full Story →